CBD Life Sciences (CBD Life Sciences) ROCE % : -15.52% (As of Sep. 2015)

View and export this data going back to 2009. Start your Free Trial

What is CBD Life Sciences ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. CBD Life Sciences's annualized ROCE % for the quarter that ended in Sep. 2015 was -15.52%.

CBD Life Sciences ROCE % Historical Data

The historical data trend for CBD Life Sciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CBD Life Sciences ROCE % Chart

CBD Life Sciences Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

ROCE %

-11.13

-34.48

-70.42

-137.96

CBD Life Sciences Quarterly Data
	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
ROCE %	Get a 7-Day Free Trial											-323.56	-21.79	-14.01	-20.69	-15.52

CBD Life Sciences ROCE % Calculation

CBD Life Sciences's annualized ROCE % for the fiscal year that ended in Dec. 2014 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2014 )		(A: Dec. 2013 )		(A: Dec. 2014 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2014 )		(A: Dec. 2013 )		(A: Dec. 2014 )
	=	-0.765	/	( ( (0.663 - 0.115)	+	(0.632 - 0.071) )	/ 2 )
	=	-0.765	/	( (0.548	+	0.561)	/ 2 )
	=	-0.765	/	0.5545
	=	-137.96 %

CBD Life Sciences's ROCE % of for the quarter that ended in Sep. 2015 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2015 )		(Q: Jun. 2015 )		(Q: Sep. 2015 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2015 )		(Q: Jun. 2015 )		(Q: Sep. 2015 )
	=	-0.088	/	( ( (0.624 - 0.045)	+	(0.621 - 0.066) )	/ 2 )
	=	-0.088	/	( ( 0.579	+	0.555 )	/ 2 )
	=	-0.088	/	0.567
	=	-15.52 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2015) EBIT data.

CBD Life Sciences (OTCPK:CBDL) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

CBD Life Sciences ROCE % Related Terms

Thank you for viewing the detailed overview of CBD Life Sciences's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

CBD Life Sciences (CBD Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CBD Life Sciences Inc (OTCPK:CBDL) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

10853 N. Frank Llyod Wright Boulevard, Suite 108, Scottsdale, AZ, USA, 85259

Website

https://lbcbioscienceinc.com

CBD Life Sciences Inc is developing and marketing a line of cannabidiol based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a full line of pet products. The company is also in the process of developing an anti-aging skin product line.